- Home
- Publications
- Publication Search
- Publication Details
Title
A New Landscape for Stroke Prevention in Atrial Fibrillation
Authors
Keywords
-
Journal
STROKE
Volume 42, Issue 11, Pages 3316-3322
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2011-10-14
DOI
10.1161/strokeaha.111.617886
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Canadian Cardiovascular Society Atrial Fibrillation Guidelines 2010: Prevention of Stroke and Systemic Thromboembolism in Atrial Fibrillation and Flutter
- (2011) John A. Cairns et al. CANADIAN JOURNAL OF CARDIOLOGY
- Dabigatran Versus Warfarin in Patients With Atrial Fibrillation
- (2011) Rangadham Nagarakanti et al. CIRCULATION
- Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part I: primary prevention
- (2011) I. Savelieva et al. EUROPACE
- Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part II: secondary prevention
- (2011) I. Savelieva et al. EUROPACE
- Mixed treatment comparison of dronedarone, amiodarone, sotalol, flecainide, and propafenone, for the management of atrial fibrillation
- (2011) N. Freemantle et al. EUROPACE
- 2011 ACCF/AHA/HRS Focused Update on the Management of Patients With Atrial Fibrillation (Update on Dabigatran)
- (2011) L. Samuel Wann et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- 2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation
- (2011) Valentin Fuster et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Bleeding risk in ‘real world’ patients with atrial fibrillation: comparison of two established bleeding prediction schemes in a nationwide cohort
- (2011) J. B. OLESEN et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Anticoagulant Options — Why the FDA Approved a Higher but Not a Lower Dose of Dabigatran
- (2011) B. Nhi Beasley et al. NEW ENGLAND JOURNAL OF MEDICINE
- Apixaban in Patients with Atrial Fibrillation
- (2011) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Apixaban versus Warfarin in Patients with Atrial Fibrillation
- (2011) Christopher B. Granger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
- (2011) Manesh R. Patel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Improving Stroke Risk Stratification Using the CHADS 2 and CHA 2 DS 2 -VASc Risk Scores in Patients With Paroxysmal Atrial Fibrillation by Continuous Arrhythmia Burden Monitoring
- (2011) Giuseppe Boriani et al. STROKE
- Cost Effectiveness of Warfarin Versus Aspirin in Patients Older Than 75 Years With Atrial Fibrillation
- (2011) Sue Jowett et al. STROKE
- Risks of thromboembolism and bleeding with thromboprophylaxis in patients with atrial fibrillation: A net clinical benefit analysis using a ‘real world’ nationwide cohort study
- (2011) Gregory Lip et al. THROMBOSIS AND HAEMOSTASIS
- Validation of the CHADS2 clinical prediction rule to predict ischaemic stroke
- (2011) Emma Wallace et al. THROMBOSIS AND HAEMOSTASIS
- Evaluation of the novel factor Xa inhibitor edoxaban compared with warfarin in patients with atrial fibrillation: Design and rationale for the Effective aNticoaGulation with factor xA next GEneration in Atrial Fibrillation–Thrombolysis In Myocardial Infarction study 48 (ENGAGE AF–TIMI 48)
- (2010) Christian T. Ruff et al. AMERICAN HEART JOURNAL
- Does Warfarin for Stroke Thromboprophylaxis Protect Against MI in Atrial Fibrillation Patients?
- (2010) Gregory Y.H. Lip et al. AMERICAN JOURNAL OF MEDICINE
- A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation
- (2010) Ron Pisters et al. CHEST
- Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)
- (2010) et al. EUROPACE
- A comparison of risk stratification schemes for stroke in 79 884 atrial fibrillation patients in general practice
- (2010) T. P. VAN STAA et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Dabigatran compared with warfarin in patients with atrial fibrillation and previous transient ischaemic attack or stroke: a subgroup analysis of the RE-LY trial
- (2010) Hans-Christoph Diener et al. LANCET NEUROLOGY
- Lenient versus Strict Rate Control in Patients with Atrial Fibrillation
- (2010) Isabelle C. Van Gelder et al. NEW ENGLAND JOURNAL OF MEDICINE
- Randomised, parallel-group, multicentre, multinational phase 2 study comparing edoxaban, an oral factor Xa inhibitor, with warfarin for stroke prevention in patients with atrial fibrillation
- (2010) Stuart Connolly et al. THROMBOSIS AND HAEMOSTASIS
- New oral anticoagulant drugs in cardiovascular disease
- (2010) Gregory Lip et al. THROMBOSIS AND HAEMOSTASIS
- Treatments for stroke prevention in atrial fibrillation: A network meta-analysis and indirect comparisons versus dabigatran etexilate
- (2010) Gregory Y. H. Lip et al. THROMBOSIS AND HAEMOSTASIS
- The CHADS2 score for stroke risk stratification in atrial fibrillation – friend or foe?
- (2010) John W. Eikelboom et al. THROMBOSIS AND HAEMOSTASIS
- Dabigatran etexilate – a novel, reversible, oral direct thrombin inhibitor: Interpretation of coagulation assays and reversal of anticoagulant activity
- (2010) Joachim Stangier et al. THROMBOSIS AND HAEMOSTASIS
- Oral direct thrombin inhibitor AZD0837 for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation: A Phase II study of AZD0837 in patients who are appropriate for but unable or unwilling to take vitamin K antagonist therapy
- (2010) Gregory Y.H. Lip et al. THROMBOSIS RESEARCH
- Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach
- (2009) Gregory Y.H. Lip et al. CHEST
- Analysis of Stroke in ATHENA: A Placebo-Controlled, Double-Blind, Parallel-Arm Trial to Assess the Efficacy of Dronedarone 400 mg BID for the Prevention of Cardiovascular Hospitalization or Death From Any Cause in Patients With Atrial Fibrillation/Atrial Flutter
- (2009) Stuart J. Connolly et al. CIRCULATION
- Oral direct thrombin inhibitor AZD0837 for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation: a randomized dose-guiding, safety, and tolerability study of four doses of AZD0837 vs. vitamin K antagonists
- (2009) G. Y.H. Lip et al. EUROPEAN HEART JOURNAL
- Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial
- (2009) David R Holmes et al. LANCET
- Dabigatran versus Warfarin in Patients with Atrial Fibrillation
- (2009) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of Dronedarone on Cardiovascular Events in Atrial Fibrillation
- (2009) Stefan H. Hohnloser et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of Age on Stroke Prevention Therapy in Patients With Atrial Fibrillation
- (2009) Carl van Walraven et al. STROKE
- Bleeding with anticoagulation therapy – Who is at risk, and how best to identify such patients
- (2009) Benilde Cosmi et al. THROMBOSIS AND HAEMOSTASIS
- Heart Disease and Stroke Statistics—2009 Update
- (2008) et al. CIRCULATION
- Consensus document on antithrombotic therapy in the setting of electrophysiological procedures
- (2008) J. J. Blanc et al. EUROPACE
- Rhythm Control versus Rate Control for Atrial Fibrillation and Heart Failure
- (2008) Denis Roy et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now